Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.
about
Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare needHow equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West EnglandInequities in access to healthcare: analysis of national survey data across six Asia-Pacific countries.Variations in cardiovascular disease under-diagnosis in England: national cross-sectional spatial analysis.Influence of population and general practice characteristics on prescribing of minor tranquilisers in primary careRegional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland.A comparison of methods for calculating general practice level socioeconomic deprivationDifferential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in EnglandInitiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysisSocioeconomic and ethnic differences in use of lipid-lowering drugs after deregulation of simvastatin in the UK: the Whitehall II prospective cohort study.Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.Ethnic inequalities in the treatment and outcome of diabetes in three English Primary Care TrustsEquity in healthcare for coronary heart disease, Wales (UK) 2004-2010: A population-based electronic cohort studyInfluence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention.Practice characteristics and prescribing of cardiovascular drugs in areas with higher risk of CHD in Scotland: cross-sectional study.Factors influencing the prescription of drugs of different price levels.Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates.An association between socioeconomic deprivation and primary care antibiotic prescribing in Scotland.Prescribing in general practice for people with coronary heart disease; equity by age, sex, ethnic group and deprivation.Correlation between use of simvastatin and lovastatin and female lung cancer risk: a nationwide case-control study.Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease - A population-wide electronic cohort study.
P2860
Q24804642-724AABC6-D214-4183-9E80-0768F5C2D6C9Q28221444-3E5B45DC-4103-422E-8582-43AD8218F3F3Q30652564-89CF9C56-5EEA-4F32-815E-1C1BCFDC6C01Q33849468-CA774C96-AFB3-430E-9C71-9FB20B159E0BQ34021656-C514C573-7741-4722-9B1D-97C294988868Q34209455-93DA7C72-5BF0-48CE-8900-47B0315DB16DQ34882942-538A1A56-5D37-453E-B747-DCAA6A333150Q35166628-80EE304C-0B27-44A4-BE96-BE3679712E14Q35179448-3FA436D4-BD9C-4939-8092-5F630CF8CF26Q35182247-4D4ED3CE-CBDF-4E6E-B68F-390F233BD5A1Q35644891-5064A136-229D-4BCB-8F36-B39AEA3DDFAAQ35827218-E708261F-356D-4456-9151-A6AB99CA7FBDQ36015784-55149B3F-7C85-450C-9656-96A0FFA2172AQ36310492-C0356B92-F736-44D2-957B-A9D46A7DEAFDQ36768429-C8316447-DDC7-41C7-8BF8-FF5C0226216CQ36791659-CCB46F50-DFCB-4873-B545-E855AB2D9215Q38076677-CCA180FB-248F-48F1-B2AC-1F0695E4984BQ44560037-75157EE0-04CA-45D5-9EE3-EE99F3127093Q45044846-ACF095A9-2E3F-49DC-A868-11DEC5F48867Q45897230-977FDCD9-8C0B-42F9-9613-916747008820Q46017191-78162150-61F5-4650-962A-3F18DF5342E7Q50609917-9D0261A9-F405-4436-8FC7-B5517B1D81FAQ52361513-9C65923D-412D-46A5-A020-A892213509E3
P2860
Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Are GP practice prescribing ra ...... rimary care trusts in England.
@ast
Are GP practice prescribing ra ...... rimary care trusts in England.
@en
type
label
Are GP practice prescribing ra ...... rimary care trusts in England.
@ast
Are GP practice prescribing ra ...... rimary care trusts in England.
@en
prefLabel
Are GP practice prescribing ra ...... rimary care trusts in England.
@ast
Are GP practice prescribing ra ...... rimary care trusts in England.
@en
P2860
P356
P1476
Are GP practice prescribing ra ...... primary care trusts in England
@en
P2093
A S St Leger
P2860
P356
10.1136/JECH.58.2.89
P50
P577
2004-02-01T00:00:00Z